With many anticipated new medicines for rare diseases, countries are beginning to prepare appropriat...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreWe’ve prepared a summary of our key market access blogs and news articles from the second quarter ...
Read moreA dive into the complex and expensive world of gene therapy pricing and access.
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreThe HST process is a method for evaluating medicines and treatments specifically indicated for ultra...
Read moreNICE’s Highly-Specialised Technologies (HST) process is a method for evaluating medicines and trea...
Read moreNICE has set out its plan using four key pillars designed to elicit incremental change within the UK...
Read moreThe highly specialised technologies (HST) process was introduced in 2013 for the purpose of evaluati...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read more